| Entry |
Curated MiRNA |
Curated LncRNA |
Predicted MiRNA |
Predicted LncRNA |
| Record |
4 |
0 |
19 |
0 |
| Compound |
ncRNA |
Type |
Condition |
Link |
| Topotecan |
hsa-miR-100-5p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-1226-5p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-125b-5p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-134 |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-199b-5p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-204-5p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-224-5p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-330-3p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-340-5p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-371a-3p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-429 |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-500a-5p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-501-5p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-506-3p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-508-3p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-514a-3p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-551b-3p |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-940 |
predicted miRNA |
NCI60 |
|
| Topotecan |
hsa-miR-99a-5p |
predicted miRNA |
NCI60 |
|
| Topotecan |
miR-17-92 |
Curated miRNA |
mantle cell lymphoma |
|
| Topotecan |
miR-502 |
Curated miRNA |
ovarian cancer |
|
| Topotecan |
miR-514 |
Curated miRNA |
ovarian cancer |
|
| Topotecan |
miR-515 |
Curated miRNA |
ovarian cancer |
|